639 related articles for article (PubMed ID: 15759279)
41. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene.
Nagy HJ; Panis Y; Fabre M; Klatzmann D; Houssin D; Soubrane O
Anticancer Res; 2000; 20(6B):4633-8. PubMed ID: 11205314
[TBL] [Abstract][Full Text] [Related]
42. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
Loimas S; Toppinen MR; Visakorpi T; Jänne J; Wahlfors J
Cancer Gene Ther; 2001 Feb; 8(2):137-44. PubMed ID: 11263529
[TBL] [Abstract][Full Text] [Related]
43. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.
Roy I; Holle L; Song W; Holle E; Wagner T; Yu X
Anticancer Res; 2002; 22(6A):3185-9. PubMed ID: 12530063
[TBL] [Abstract][Full Text] [Related]
44. [Effects of herpes simplex virus thymidine kinase gene transduction and prodrug on ovarian cancer cell].
Liang Z; Kuang J; Lin Z
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):467-70. PubMed ID: 9639739
[TBL] [Abstract][Full Text] [Related]
45. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C
Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568
[TBL] [Abstract][Full Text] [Related]
46. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
[TBL] [Abstract][Full Text] [Related]
47. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.
Hu WX; Zeng ZJ; Luo SQ; Chen Q
Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787
[TBL] [Abstract][Full Text] [Related]
48. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
49. [The effect of lentivirus-mediated suicide gene therapy on lens epithelial cells].
Yang J; Lu Y; Guo LH; Liu TJ; Mo XF
Zhonghua Yan Ke Za Zhi; 2007 Sep; 43(9):810-6. PubMed ID: 18070527
[TBL] [Abstract][Full Text] [Related]
50. Intercellular trafficking of VP22-GFP fusion proteins.
Elliott G; O'Hare P
Gene Ther; 1999 Jan; 6(1):149-51. PubMed ID: 10341888
[TBL] [Abstract][Full Text] [Related]
51. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
[TBL] [Abstract][Full Text] [Related]
52. [Lethal effect of adenovirus-mediated HSV-TK gene in combination with hydroxycamptothecin on human bladder cancer in vitro].
Huang H; Tan WL; Zhu WH; Liang ZK
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):461-4. PubMed ID: 17545031
[TBL] [Abstract][Full Text] [Related]
53. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
[TBL] [Abstract][Full Text] [Related]
54. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
[TBL] [Abstract][Full Text] [Related]
55. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
56. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
[TBL] [Abstract][Full Text] [Related]
57. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing.
Black ME; Kokoris MS; Sabo P
Cancer Res; 2001 Apr; 61(7):3022-6. PubMed ID: 11306482
[TBL] [Abstract][Full Text] [Related]
58. [Targeted killing effect of mucin-1 single chain antibody targeting, lentivirus-mediated suicide gene therapy and ganciclovir in mucin-1+ ovarian epithelial carcinoma cells].
Song L; Kong B; Liu C
Zhonghua Fu Chan Ke Za Zhi; 2001 Oct; 36(10):610-3. PubMed ID: 16134525
[TBL] [Abstract][Full Text] [Related]
59. Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapy.
Berlinghoff S; Veldwijk MR; Laufs S; Maser HP; Jauch A; Wenz F; Jens Zeller W; Fruehauf S
Lung Cancer; 2004 Nov; 46(2):179-86. PubMed ID: 15474666
[TBL] [Abstract][Full Text] [Related]
60. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells.
Fang B; Xu B; Koch P; Roth JA
Gene Ther; 1998 Oct; 5(10):1420-4. PubMed ID: 9930348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]